Log in

Corteva Stock Forecast, Price & News

-0.59 (-1.99 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $28.99
50-Day Range
MA: $28.37
52-Week Range
Now: $28.99
Volume7.09 million shs
Average Volume4.96 million shs
Market Capitalization$21.70 billion
P/E Ratio42.63
Dividend Yield1.76%
Corteva, Inc. provides agriculture products worldwide. The company develops and supplies germplasm and traits in corn, soybean, and sunflower seed markets. It also supplies products to the agricultural input industry that protect against weeds, insects and other pests, and diseases, as well as to enhance crop health. The company is based in Wilmington, Delaware. Corteva, Inc. operates independently of DowDuPont Inc. as of June 1, 2019.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.2Community Rank: 2.2Dividend Strength: 2.5Insider Behavior: 4.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.56 out of 5 stars

Industry, Sector and Symbol

Industry Agricultural production - crops



Sales & Book Value

Annual Sales$13.85 billion
Cash Flow$5.40 per share
Book Value$32.81 per share


Net Income$-959,000,000.00


Market Cap$21.70 billion
Next Earnings Date10/29/2020 (Estimated)
OptionableNot Optionable
-0.59 (-1.99 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CTVA News and Ratings via Email

Sign-up to receive the latest news and ratings for CTVA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Corteva (NYSE:CTVA) Frequently Asked Questions

How has Corteva's stock been impacted by COVID-19 (Coronavirus)?

Corteva's stock was trading at $25.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CTVA stock has increased by 16.0% and is now trading at $28.99.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Corteva?

23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Corteva in the last year. There are currently 1 sell rating, 10 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Corteva

When is Corteva's next earnings date?

Corteva is scheduled to release its next quarterly earnings announcement on Thursday, October 29th 2020.
View our earnings forecast for Corteva

How were Corteva's earnings last quarter?

Corteva (NYSE:CTVA) issued its quarterly earnings results on Wednesday, August, 5th. The company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.20 by $0.06. The company earned $5.19 billion during the quarter, compared to the consensus estimate of $5.36 billion. Corteva had a return on equity of 4.67% and a net margin of 3.68%.
View Corteva's earnings history

How often does Corteva pay dividends? What is the dividend yield for Corteva?

Corteva declared a quarterly dividend on Wednesday, July 15th. Investors of record on Friday, August 14th will be paid a dividend of $0.13 per share on Tuesday, September 15th. This represents a $0.52 dividend on an annualized basis and a yield of 1.79%. The ex-dividend date of this dividend is Thursday, August 13th.
View Corteva's dividend history

What guidance has Corteva issued on next quarter's earnings?

Corteva issued an update on its FY20 earnings guidance on Wednesday, August, 5th. The company provided EPS guidance of $1.25-1.45 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.39. The company issued revenue guidance of +1-2% (implying $14-14.1 billion), compared to the consensus revenue estimate of $14.18 billion.

What price target have analysts set for CTVA?

23 analysts have issued 1 year target prices for Corteva's shares. Their forecasts range from $24.00 to $39.00. On average, they anticipate Corteva's stock price to reach $30.53 in the next year. This suggests a possible upside of 5.3% from the stock's current price.
View analysts' price targets for Corteva

Are investors shorting Corteva?

Corteva saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 14,810,000 shares, an increase of 80.8% from the August 15th total of 8,190,000 shares. Based on an average trading volume of 4,580,000 shares, the days-to-cover ratio is presently 3.2 days. Currently, 2.0% of the company's stock are sold short.
View Corteva's Short Interest

Who are some of Corteva's key competitors?

What other stocks do shareholders of Corteva own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Corteva investors own include Cisco Systems (CSCO), AT&T (T), Verizon Communications (VZ), Johnson & Johnson (JNJ), NVIDIA (NVDA), CVS Health (CVS), Intel (INTC), Pfizer (PFE), QUALCOMM (QCOM) and Home Depot (HD).

What is Corteva's stock symbol?

Corteva trades on the New York Stock Exchange (NYSE) under the ticker symbol "CTVA."

Who are Corteva's major shareholders?

Corteva's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (10.07%), Independent Franchise Partners LLP (2.45%), Eminence Capital LP (0.86%), State Farm Mutual Automobile Insurance Co. (0.84%), Principal Financial Group Inc. (0.67%) and Principal Financial Group Inc. (0.67%). Company insiders that own Corteva stock include Cornel B Fuerer, Gregory R Friedman, Gregory R Page, James C Jr Collins, Klaus A Engel, Rajan Gajaria and Timothy P Glenn.
View institutional ownership trends for Corteva

Which major investors are selling Corteva stock?

CTVA stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., State of Tennessee Treasury Department, Cibc World Markets Corp, Prudential PLC, TCW Group Inc., Toronto Dominion Bank, FIL Ltd, and FMR LLC.
View insider buying and selling activity for Corteva

Which major investors are buying Corteva stock?

CTVA stock was bought by a variety of institutional investors in the last quarter, including Independent Franchise Partners LLP, Holocene Advisors LP, State Farm Mutual Automobile Insurance Co., Jacobs Levy Equity Management Inc., Principal Financial Group Inc., Principal Financial Group Inc., MUFG Securities EMEA plc, and Healthcare of Ontario Pension Plan Trust Fund. Company insiders that have bought Corteva stock in the last two years include Cornel B Fuerer, Gregory R Friedman, Gregory R Page, James C Jr Collins, Klaus A Engel, Rajan Gajaria, and Timothy P Glenn.
View insider buying and selling activity for Corteva

How do I buy shares of Corteva?

Shares of CTVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Corteva's stock price today?

One share of CTVA stock can currently be purchased for approximately $28.99.

How big of a company is Corteva?

Corteva has a market capitalization of $21.70 billion and generates $13.85 billion in revenue each year. The company earns $-959,000,000.00 in net income (profit) each year or $1.43 on an earnings per share basis.

What is Corteva's official website?

The official website for Corteva is www.corteva.com.

How can I contact Corteva?

Corteva's mailing address is 974 CENTRE ROAD, WILMINGTON DE, 19805. The company can be reached via phone at 302-485-3000.

This page was last updated on 9/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.